These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20218806)

  • 1. Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity.
    Damm J; Eser D; Moeller HJ; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):516-8. PubMed ID: 20218806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolpidem dependence in a patient with former polysubstance abuse.
    Bottlender R; Schütz C; Möller HJ; Soyka M
    Pharmacopsychiatry; 1997 May; 30(3):108. PubMed ID: 9211573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
    Vlainić J; Pericić D
    Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management.
    Liappas IA; Malitas PN; Dimopoulos NP; Gitsa OE; Liappas AI; Nikolaou ChK; Christodoulou GN
    J Psychopharmacol; 2003 Mar; 17(1):131-5. PubMed ID: 12680751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
    Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
    Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
    Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem is a potent anticonvulsant in adult and aged mice.
    Vlainić J; Pericić D
    Brain Res; 2010 Jan; 1310():181-8. PubMed ID: 19914223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
    Mirza NR; Rodgers RJ; Mathiasen LS
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem for postanoxic spasticity.
    Shadan FF; Poceta JS; Kline LE
    South Med J; 2004 Aug; 97(8):791-2. PubMed ID: 15352681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of alphak/gamma2 (k=1, 2, 3 and 5) interface of GABA A receptor and docking studies with zolpidem: implications for selectivity.
    Ci SQ; Ren TR; Ma CX; Su ZG
    J Mol Graph Model; 2007 Sep; 26(2):537-45. PubMed ID: 17451983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure following sudden zolpidem withdrawal.
    Cubała WJ; Landowski J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):539-40. PubMed ID: 16950552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of zolpidem in the treatment of progressive supranuclear palsy.
    Cotter C; Armytage T; Crimmins D
    J Clin Neurosci; 2010 Mar; 17(3):385-6. PubMed ID: 20071178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation.
    Cope DW; Halbsguth C; Karayannis T; Wulff P; Ferraguti F; Hoeger H; Leppä E; Linden AM; Oberto A; Ogris W; Korpi ER; Sieghart W; Somogyi P; Wisden W; Capogna M
    Eur J Neurosci; 2005 Jun; 21(11):3002-16. PubMed ID: 15978011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
    J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
    Laurén HB; Lopez-Picon FR; Kukko-Lukjanov TK; Uusi-Oukari M; Holopainen IE
    Neuroscience; 2007 May; 146(2):802-11. PubMed ID: 17360122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.
    Sethi PK; Khandelwal DC
    J Assoc Physicians India; 2005 Feb; 53():139-40. PubMed ID: 15847035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of blepharospasm with Zolpidem.
    Garretto NS; Bueri JA; Rey RD; Arakaki T; Nano GV; Mancuso M
    Mov Disord; 2004 Aug; 19(8):967-8. PubMed ID: 15300667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
    Rowlett JK; Spealman RD; Lelas S
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.